Literature DB >> 15280398

Genetic pathways to melanoma tumorigenesis.

M R Hussein1.   

Abstract

The incidence of cutaneous malignant melanomas is growing faster than that of any other cancer and therefore posing a major heath threat worldwide. In melanocytic skin tumours, the feasibility of correlating a specific pathological stage with a corresponding genetic alteration provides a remarkable opportunity to study the multistep tumorigenesis model. This multistep melanoma tumorigenesis is best described as a continuum of transformation of the melanocytes, melanocytic dysplasia, and melanoma formation. These steps involve genotypic alterations including loss of tumour suppressor genes, microsatellite instability, and alterations of the mismatch repair system. This review seeks to examine melanoma tumorigenesis based on these genetic changes.

Entities:  

Mesh:

Year:  2004        PMID: 15280398      PMCID: PMC1770385          DOI: 10.1136/jcp.2003.015800

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  52 in total

1.  Identification of novel deletion Loci at 1p36 and 9p22-21 in melanocytic dysplastic nevi and cutaneous malignant melanomas.

Authors:  Mahmoud R Hussein; Eduardo Roggero; Ralph J Tuthill; Gary S Wood; Oscar Sudilovsky
Journal:  Arch Dermatol       Date:  2003-06

2.  Microsatellite analysis in cutaneous malignant melanoma.

Authors:  D Massi; I Sardi; C Urso; A Franchi; L Borgognoni; A Salvadori; A Giannini; U M Reali; M Santucci
Journal:  Melanoma Res       Date:  2002-12       Impact factor: 3.599

Review 3.  Microsatellite instability and its relevance to cutaneous tumorigenesis.

Authors:  Mahmoud R Hussein; Gary S Wood
Journal:  J Cutan Pathol       Date:  2002-05       Impact factor: 1.587

4.  Genotypic analysis of primary and metastatic cutaneous melanoma.

Authors:  U N M Rao; M W Jones; S D Finkelstein
Journal:  Cancer Genet Cytogenet       Date:  2003-01-01

5.  Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign naevi, dysplastic naevi, and primary melanomas and their metastases.

Authors:  Giuseppe Palmieri; Paolo A Ascierto; Antonio Cossu; Maria Colombino; Milena Casula; Gerardo Botti; Amelia Lissia; Francesco Tanda; Giuseppe Castello
Journal:  Melanoma Res       Date:  2003-04       Impact factor: 3.599

6.  DNA microarrays and likelihood ratio bioinformatic methods: discovery of human melanocyte biomarkers.

Authors:  Thomas P Dooley; Ernest V Curto; Richard L Davis; Paola Grammatico; Edward S Robinson; Teresa W Wilborn
Journal:  Pigment Cell Res       Date:  2003-06

7.  Gene expression profiling of melanocytic lesions.

Authors:  John T Seykora; Debbie Jih; Rosalie Elenitsas; Wen-Hwai Horng; David E Elder
Journal:  Am J Dermatopathol       Date:  2003-02       Impact factor: 1.533

8.  hMLH1 and hMSH2 gene mutations are present in radial growth-phase cutaneous malignant melanoma cell lines and can be induced further by ultraviolet-B irradiation.

Authors:  Mahmoud R Hussein; Gary S Wood
Journal:  Exp Dermatol       Date:  2003-12       Impact factor: 3.960

9.  Loss of heterozygosity, microsatellite instability, and mismatch repair protein alterations in the radial growth phase of cutaneous malignant melanomas.

Authors:  Mahmoud R Hussein; Min Sun; Eduardo Roggero; Eulalia C Sudilovsky; Ralph J Tuthill; Gary S Wood; Oscar Sudilovsky
Journal:  Mol Carcinog       Date:  2002-05       Impact factor: 4.784

10.  Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study.

Authors:  Soledad R Alonso; Pablo Ortiz; Marina Pollán; Beatriz Pérez-Gómez; Lydia Sánchez; Ma Jesús Acuña; Raquel Pajares; Francisco J Martínez-Tello; Carlos M Hortelano; Miguel A Piris; José L Rodríguez-Peralto
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

View more
  19 in total

Review 1.  Melanoma of the head and neck.

Authors:  Terry A Day; Joshua D Hornig; Anand K Sharma; Frank Brescia; M Boyd Gillespie; Deanne Lathers
Journal:  Curr Treat Options Oncol       Date:  2005-01

2.  Mutational status of naevus-associated melanomas.

Authors:  D Shitara; G Tell-Martí; C Badenas; M M S S Enokihara; L Alós; A B Larque; N Michalany; J A Puig-Butille; C Carrera; J Malvehy; S Puig; E Bagatin
Journal:  Br J Dermatol       Date:  2015-06-19       Impact factor: 9.302

3.  Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions.

Authors:  M R Hussein; D A H Elsers; S A Fadel; A-E M Omar
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

4.  Retrospective multicenter evaluation of patients diagnosed with mucosal melanoma: a study of Anatolian Society of Medical Oncology.

Authors:  Ozlem Ercelep; Turkan Ozturk Topcu; Ibrahim Vedat Bayoglu; Ahmet Siyar Ekinci; Sinan Koca; Halil Kavgaci; Melike Ozcelik; Ahmet Alacacioglu; Sernaz Uzunoglu; Oktay Bozkurt; Arife Ulas; Asude Aksoy; Burcu Yapar Taskoylu; Ozge Gumussay; Sebnem Yaman; Mukremin Uysal; Dincer Aydin; Mahmut Gumus
Journal:  Tumour Biol       Date:  2016-05-12

5.  Single nucleotide polymorphism profiling assay to confirm the identity of human tissues.

Authors:  Ronald Huijsmans; Jan Damen; Hans van der Linden; Mirjam Hermans
Journal:  J Mol Diagn       Date:  2007-04       Impact factor: 5.568

6.  Correlation of cell cycle regulatory proteins (p53 and p16(ink)⁴(a)) and bcl-2 oncoprotein with mitotic index and thickness of primary cutaneous malignant melanoma.

Authors:  Miloš Kostov; Zaklina Mijović; Dragan Mihailović; Snežana Cerović; Miroslav Stojanović; Marija Jelić
Journal:  Bosn J Basic Med Sci       Date:  2010-11       Impact factor: 3.363

Review 7.  Tumour-associated macrophages and melanoma tumourigenesis: integrating the complexity.

Authors:  Mahmoud R Hussein
Journal:  Int J Exp Pathol       Date:  2006-06       Impact factor: 1.925

Review 8.  Isolated limb infusion as a model to test new agents to treat metastatic melanoma.

Authors:  Michael E Lidsky; Paul J Speicher; Betty Jiang; Masahito Tsutsui; Douglas S Tyler
Journal:  J Surg Oncol       Date:  2013-11-20       Impact factor: 3.454

9.  Microradiopharmaceutical for Metastatic Melanoma.

Authors:  Thiago Goulart Rosa; Sofia Nascimento Dos Santos; Terezina de Jesus Andreoli Pinto; Daniele Dal Molim Ghisleni; Thereza Christina Barja-Fidalgo; Eduardo Ricci-Junior; Mohammed Al-Qahtani; Jan Kozempel; Emerson Soares Bernardes; Ralph Santos-Oliveira
Journal:  Pharm Res       Date:  2017-10-23       Impact factor: 4.200

10.  Telomere-centromere-driven genomic instability contributes to karyotype evolution in a mouse model of melanoma.

Authors:  Amanda Gonçalves Dos Santos Silva; Herbert Alexander Graves; Amanda Guffei; Tatiana Iervolino Ricca; Renato Arruda Mortara; Miriam Galvonas Jasiulionis; Sabine Mai
Journal:  Neoplasia       Date:  2010-01       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.